Price to Sales ratio Analysis of Phathom Pharmaceuticals Inc - Deep Dive
Latest FY PS
Period Ending - Dec-23
Very Poor PS
853564
Period Ending - Dec-22
Very Poor PS
0
Growth
0 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
171333
PS Analysis of Phathom Pharmaceuticals Inc
P/S Ratio of Phathom Pharmaceuticals Inc with value of 171333 indicates that stock price is high compared to sales of the company and may be overvalued. |
PS Ratio of PHAT has grown by 0 % Compared to previous Financial Year. |
PS Ratio with value of 853564 was highest in Year Dec-23 in last Five Years. |
PS Ratio with value of 0 was lowest in Year Dec-22 in last Five Years. |
Latest PS Ratio with value of 853564 is Greater than Average PS of 170712 in last five years. |
Other PS Related Info of PHAT that may interest you.
Phathom Pharmaceuticals Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
PHAT | 11.35 | 10.95 | 3.65 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..PS Related Ratios
PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
Poor Value Stock |
FY - Historical Price to Sales of Phathom Pharmaceuticals Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
---|---|---|---|---|---|---|
PS | 853564 | 0 | 0 | 0 | 0 | 0 |
Change |
FY Chart of Price to Sales of Phathom Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)